Detalhe da pesquisa
1.
Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.
Clin Ther
; 28(8): 1175-1180, 2006 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16982294
2.
Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients.
Respir Med
; 100(12): 2129-36, 2006 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-16730170
3.
High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm.
Clin Infect Dis
; 37(6): 752-60, 2003 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12955634
4.
Levofloxacin efficacy in the treatment of community-acquired legionellosis.
Chest
; 125(6): 2135-9, 2004 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-15189933
5.
Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.
Curr Med Res Opin
; 20(9): 1473-81, 2004 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-15383197
6.
Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens.
Curr Med Res Opin
; 20(4): 555-63, 2004 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-15119993
7.
Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infections.
Curr Med Res Opin
; 22(10): 1997-2006, 2006 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-17022859